Denosumab for treatment of breast cancer bone metastases and beyond

By Nangia Julie R   Ma Joseph D   Nguyen Christine M   Mendes Margaret AS   Trivedi Meghana V  

Expert Opinion on Biological Therapy, Vol. 12, Iss. 4, 2012-04 ,pp. : 491-501

Informa Healthcare

Access to resources Recommend Favorite

Low serum MMP-1 in breast cancer: a negative prognostic factor?

By Kulić A.   Dedić Plavetić N.   Vrbanec J.   Sirotković-Skerlev M.  

Biomarkers, Vol. 17, Iss. 5, 2012-08 ,pp. : 416-421

Informa Healthcare

Access to resources Recommend Favorite

Serum and tissue trace elements in patients with breast cancer in Taiwan

By Kuo Hsien   Chen Su   Wu Chin   Chen Dar   Lee Jau  

Biological Trace Element Research, Vol. 89, Iss. 1, 2002-10 ,pp. : 1-11

Humana Press, Inc

Access to resources Recommend Favorite

Differential Expression of Alternatively Spliced c-erbB-2 mRNA in Primary Tumors, Lymph Node Metastases, and Bone Marrow Micrometastases from Breast Cancer Patients

By Gebhardt F.   Zanker K.S.   Brandt B.  

Biochemical and Biophysical Research Communications, Vol. 247, Iss. 2, 1998-06 ,pp. : 319-323

Elsevier

Access to resources Recommend Favorite

Matrix metalloproteinase-2 (MMP-2) and -9 (MMP-9) in preoperative serum as independent prognostic markers in patients with colorectal cancer

By Dragutinović Vesna   Radonjić Nevena   Petronijević Nataša   Tatić Svetislav   Dimitrijević Ivan   Radovanović Nebojša   Krivokapić Zoran  

Molecular and Cellular Biochemistry, Vol. 355, Iss. 1-2, 2011-09 ,pp. : 173-178

Springer Publishing Company

Access to resources Recommend Favorite